it's just the beginning for Cirralto!, page-6871

Not really I'm just lifting up the hood of the business prospectus to see if there are any glaring issues

So far I've found a few, some may be knon issues but it's good to chat about the inner workings of this unproven model to see what flaws it may present at market

Yes it's risky at $100m market cap with limited track record, proven inability to turn any of the multiple capital raisings into revenue, directors playing musical chairs and bleeding Adam to pay Eve, then buying Eve to boot, 1.8bln+ in shares and options yes I'd say it's one of the more risky stocks on the bourse

Doesn't mean it's not a buy, just trying to decipher if this product spec works in the real world and possible uptake etc

cheers